Search By Initial

Name Index L

• LY2409881 trihydrochloride (Catalog# : 101914, Cas# : 946518-60-1)LY2409881 trihydrochloride is a novel selective inhibitor of IKK2 with IC50 of 30 nM;
• LHW090-A7 (Catalog# : 91810, Cas# : 1308256-94-1)Coming soon!
• L189 (Catalog# : 91001, Cas# : 64232-83-3)L189 inhibits base excision repair (BER) and non-homologous end joining (NHEJ), which
• Linagliptin (Catalog# : 82608, Cas# : 668270-12-0)Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM.
• Lurasidone hydrochloride (Catalog# : 81313, Cas# : 367514-87-2)Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma, which
• LRRK2-IN-1 (Catalog# : 81001, Cas# : 1234480-84-2)LRRK2-IN-1 is a cell-permeable, ATP competitive, potent, and selective LRRK2 inhibito
• LY2874455 (Catalog# : 71801, Cas# : 1254473-64-7)1) Sponsor: Eli Lilly and Company.2) Phase:Phase 12) LY2874455 is potent, selective,
• LDK378 (Catalog# : 52806, Cas# : 1032900-25-6)LDK378(Ceritinib) is potent inhibitor against ALK with IC50 of 0.2 nM, shows 40- and
• LDN193189 (Catalog# : 52733, Cas# : 1062368-24-4)LDN193189(DM 3189) is a selective BMP signaling inhibitor, inhibits the transcription
• LDN-214117 (Catalog# : 52707, Cas# : 1627503-67-6)LDN-214117 is a potent and selective ALK2 inhibitor with IC50 of 22 nM; > 100 fold
• LDN-212854 (Catalog# : 52588, Cas# : 1432597-26-6)LDN-212854 is a potent and selectiveBMP receptorinhibitor with IC50 of 1.3 nM for ALK
• LB-100 (Catalog# : 52511, Cas# : 1026680-07-8)LB-100 is a small-molecular protein phosphatase 2A(PP2A)inhibitor with IC50 of 0.85 M
• LY-364947 (Catalog# : 52509, Cas# : 396129-53-6)LY364947 is a potent ATP-competitive inhibitor of TGFR-I with IC50 of 59 nM, exhibits
• LH846 (Catalog# : 51504, Cas# : 639052-78-1)LH846 is a selective inhibitor of CK1 (IC50 values are 290 nM, 1.3 uM and 2.5 uM for
• LY294002 (Catalog# : 52309, Cas# : 154447-36-6)LY294002 is the first synthetic molecule known to inhibitPI3K//withIC50of 0.5 M/0.57
• LFM-A13 (Catalog# : 52206, Cas# : 244240-24-2)Selective Bruton's tyrosine kinase (BTK) inhibitor (IC50 = 2.5 M). Also inhibits poli
• Luminespib ( NVP-AUY922 ; VER-52296 ) (Catalog# : 51703, Cas# : 747412-49-3)NVP-AUY922 is an experimental drug candidate for the treatment of cancer. It was disc